I was just medling with medical archives to learn more about David Stamler.
He was the chief medical officer of Auspex which got bought by Teva for $3.5B. SD-809 was the lead candidate drug for treating chorea. The drug got FDA approval in 2017
This impeccable record could be the reason Stamler is paid a hefty salary. I will not be surprised if ATH434 walks in the footsteps of SD-809
I will wait until the end. I'm not releasing my shares.
- Forums
- ASX - By Stock
- ATH
- Ann: Alterity Therapeutics Raises $4.8M AUD in Placement
Ann: Alterity Therapeutics Raises $4.8M AUD in Placement, page-24
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $26.22M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $10.54K | 2.185M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
59 | 83226460 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 20397608 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
59 | 83226460 | 0.004 |
50 | 53735564 | 0.003 |
16 | 38993014 | 0.002 |
12 | 93270101 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 20397608 | 18 |
0.006 | 16372811 | 23 |
0.007 | 17174670 | 18 |
0.008 | 14585875 | 16 |
0.009 | 6171000 | 7 |
Last trade - 10.13am 07/06/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |